Project Grant R44GM137649

The National Science Foundation (NSF) Division of Chemistry awarded a $480,000 Project Grant to Virginia Commonwealth University (VCU) to improve the separation of complex biological samples by exploring the use of mixed-mode gradient stationary phases for liquid chromatography (LC). This 3-year project, funded under the Mathematical and Physical Sciences program (CFDA 47.049), aims to develop new approaches to strategically modify particle-packed silica columns with functionalized...

Grant Award Summary Washington State University, under the direction of Professor Brian H. Clowers, received a $485,838 Project Grant award from the National Science Foundation's Division of Chemistry (CFDA 47.049 – Mathematical and Physical Sciences) effective September 1, 2025, through August 31, 2028. The grant supports the development of a novel analytical platform for advancing chemical separations through multimodal ion chemistry and tandem ion mobility spectrometry. The research team will...

Partillion Bioscience Corp. was awarded a $659,037 Project Grant from the National Institutes of Health's National Institute of General Medical Sciences to develop reagent products enabling high-throughput screening and selection of single cells based on secreted bio-products. Under the Biomedical Research and Research Training program (CFDA 93.859), Partillion plans to transition its lab-on-a-particle technology—highlighted as a 2020 SLAS Innovation Award winner—into the first reagent product...

Federal Grant Award Summary Piccolo Biosystems, Inc. received a $295,861 Phase I Small Business Innovation Research (SBIR) award from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025 through August 31, 2026. In collaboration with the University of Washington, Piccolo will develop and validate an innovative ultra-small scale assay platform for measuring enzyme inhibition, specifically...

This $298,143 National Science Foundation project grant will support the development of a portable instrument for measuring poly- and perfluoroalkyl substances (PFAS) by the University of Texas at Arlington from September 2022 through August 2025. PFAS are man-made chemicals used in firefighting foams and cleaning products that accumulate in the environment and pose health risks. Typically analyzed using expensive laboratory equipment, this new portable instrument aims to reliably measure...

Federal Project Grant Award Summary Vivid Bioinnovations, PBC (operating as Fluid Discovery, Inc.) received a $306,872 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) for the period August 1, 2025 through July 31, 2026. The award supports development of a commercial prototype for an ultrahigh-throughput biocatalyst evolution platform that combines precision nanoliter fluid handling, label-free...

Grant Award Summary The National Science Foundation's Division of Chemistry, under the Mathematical and Physical Sciences program (CFDA 47.049), awarded $442,515 to Gustavus Adolphus College for a three-year project (August 1, 2025 – July 31, 2028) titled "GOALI: Technologies to Support the New Era of Liquid Chromatography Research." This academic-industry collaboration with Agilent Technologies, led by Professor Dwight Stoll, focuses on developing innovative technologies in two...

Micropure Genomics Inc. received a $274,199 Project Grant award from the National Science Foundation to advance methods for rapid, end-to-end sample preparation for sequencing applications. Under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084), the company will develop an automated process relying on electro-hydrodynamic trapping to isolate genomic material like DNA or RNA from cells in a flow cartridge. The process aims to significantly reduce preparation time while...

Federal Project Grant Award Summary OWIC Technologies Inc. received a $290,670 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) to develop Smart Photoelectronics for Electrochemical Synthesis (SPECS)—an innovative technology platform designed to democratize high-throughput electrosynthesis for pharmaceutical drug discovery. The award, effective August 1, 2025, through July 31, 2026, supports...

Grant Award Summary Spectral Therapeutics, Inc. received a $322,388 Project Grant award from the National Center for Advancing Translational Sciences (NCATS, CFDA 93.350) effective August 1, 2025, through July 31, 2026, to develop and validate an optical-encoded bead technology platform for large-scale molecular library generation. The project addresses a critical bottleneck in combinatorial drug discovery by creating stimulated emission-encoded beads that enable instantaneous decoding during...